Maureen Caracena Ty

Maureen Caracena Ty

Auto-generated profile, based on publicly available information

Maureen Caracena Ty

Department of Medicine, Stanford University, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
MTMaureen Ty
Maureen Ty
SSShenghuan Sun
Shenghuan Sun
PCPerri C. Callaway
Perri C. Callaway
JRJohn Rek
John Rek
KPKathleen D. Press
Kathleen D. Press
PJPrasanna Jagannathan
Prasanna Jagannathan
Natural killer (NK) cells likely play an important role in immunity to malaria, but the effect of repeated malaria on NK cell responses remains unclear. Here, we comprehensively profiled the NK cell response in a cohort of 264 Ugandan children. Repeated malaria exposure was associated with expansion of an atypical, CD56 neg population of NK cells that differed transcriptionally, epigenetically, and phenotypically from CD56 dim NK cells, including decreased expression of PLZF and the Fc receptor γ-chain, increased histone methylation, and increased protein expression of LAG-3, KIR, and LILRB1. CD56 neg NK cells were highly functional and displayed greater antibody-dependent cellular cytotoxicity than CD56 dim NK cells. Higher frequencies of CD56 neg NK cells were associated with protection against symptomatic malaria and high parasite densities. After marked reductions in malaria transmission, frequencies of these cells rapidly declined, suggesting that continuous exposure to Plasmodium falciparum is required to maintain this modified, adaptive-like NK cell subset.

3 February 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
KPKattria van der Ploeg
Kattria van der Ploeg
AKAdam Setori Kirosingh
Adam Setori Kirosingh
DMDiego Alonzo Martinez Mori
Diego Alonzo Martinez Mori
SCSaborni Chakraborty
Saborni Chakraborty
ZHZicheng Hu
Zicheng Hu
PJPrasanna Jagannathan
Prasanna Jagannathan
SARS-CoV-2-specific CD4+ T cells are likely important in immunity against COVID-19, but our understanding of CD4+ longitudinal dynamics following infection, and specific features that correlate with the maintenance of neutralizing antibodies, remains limited. We characterized SARS-CoV-2-specific CD4 + T cells in a longitudinal cohort of 109 COVID-19 outpatients. The quality of the SARS-CoV-2-specific CD4 + response shifted from cells producing IFNγ to TNFα from five days to four months post-enrollment, with IFNγ- IL21- TNFα+ CD4+ T cells the predominant population detected at later timepoints. Greater percentages of IFNγ- IL21- TNFα+ CD4+ T cells on day 28 correlated with SARS-CoV-2 neutralizing antibodies measured seven months post-infection (⍴=0.4, P=0.01). mRNA vaccination following SARS-CoV-2 infection boosted both IFNγ and TNFα producing, spike protein-specific CD4 + T cells. These data suggest that SARS-CoV-2-specific, TNFα-producing CD4 + T cells may play an important role in antibody maintenance following COVID-19. Funding: This study was supported by NIH/NIAID (U01 AI150741-01S1 to Z.H., S.T., I.R.B., B.G., T.T.W., and P.J.), the Stanford’s Innovative Medicines Accelerator, and a Fastgrant (C.A.B.). The Lambda clinical trial was funded by anonymous donors to Stanford University, and Peginterferon Lambda provided by Eiger BioPharmaceuticals. Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: All participants gave written informed consent. The study protocol used was approved by the Institutional Review Board of Stanford University.

13 October 2026 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
CMCaitlin E. McColloch
Caitlin E. McColloch
MDMeagan Davis
Meagan Davis
JBJoi Barkley
Joi Barkley
JJJesica Jacobs
Jesica Jacobs
MTMaureen C. Ty
Maureen C. Ty
TMTara C. Mohr
Tara C. Mohr
Context: Training laboratory professionals as public health leaders is essential for building resilient public health systems. Public health leadership training is complex and requires intentional investment in developing soft skills (eg, communications, emotional intelligence, building trust). Program: The US Center for Disease Control and Prevention's Laboratory Leadership Service (LLS) fellowship program trains laboratory professionals to be future public health leaders. In 2022, LLS implemented an enhanced leadership curriculum designed to empower LLS officers to take ownership of their roles and effectively apply leadership skills to expand their professional development and the performance of their teams. Implementation: LLS's enhanced leadership curriculum includes didactic leadership training, senior leader panels, peer-to-peer leadership activities, and personalized coaching regarding individual leadership action plans targeting specific growth areas within defined competencies. Officers complete pre- and postprogram assessments to reflect on and monitor leadership development progress. Assessment: We analyzed qualitative feedback from LLS officers, self-reported officer assessment data, and supervisor evaluations of officers' leadership-related attitudes and behaviors. We assessed possible effects of the enhanced leadership curriculum on officer leadership-related attitudes and behaviors and sought to understand the curriculum from officers' perspectives. Discussion: Self-reported and supervisor-reported data indicate perceived improvements in leadership-related attitudes and behaviors among officers. The extent to which this is linked to the enhanced curriculum remains uncertain. This article highlights potential benefits of integrated, personalized leadership training and offers insights into refining and assessing early career leadership programs. Future evaluations might explore applicability of this enhanced leadership curriculum model across other training contexts.